Learn more

FOSHAN SAIWEISI MEDICAL TECHNOLOGY CO LTD

Overview
  • Total Patents
    23
  • GoodIP Patent Rank
    70,831
About

FOSHAN SAIWEISI MEDICAL TECHNOLOGY CO LTD has a total of 23 patent applications. Its first patent ever was published in 2015. It filed its patents most often in China. Its main competitors in its focus markets organic fine chemistry are HUNAN SIYIKANG BIOTECHNOLOGY CO LTD, SHANDONG INST PHARMACEUTICAL INDUSTRY and KACANI STANISLAV.

Patent filings in countries

World map showing FOSHAN SAIWEISI MEDICAL TECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 23

Patent filings per year

Chart showing FOSHAN SAIWEISI MEDICAL TECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

Focus technologies

# Technology
#1 Heterocyclic compounds

Top inventors

# Name Total Patents
#1 Cai Ziyang 23

Latest patents

Publication Filing date Title
CN105085416A Nitro-substituted bisalcoxylbenzoquinazoline tyrosine kinase inhibitor and application
CN105085414A Novel benzoquinazoline tyrosine kinase inhibitor and preparation method and application thereof
CN105085415A Nitro-substituted benzo-quinazoline tyrosine kinase inhibitor and application thereof
CN104987314A Compound containing benzisoxazole and structure with nitryl and benzyl groups at the tail end and application thereof
CN104987312A Aminobenzene triazole sulfoxide 11 beta-HSD1 inhibitor and application thereof
CN104987313A Terminal-substituted triazole sulfoxide compound, preparation method thereof and application thereof
CN104788424A PTP1B inhibitors containing nicotinamide and piperidine structure, and preparation method and use thereof
CN104788425A PTP1B inhibitors containing nicotinamide and piperidine structure, and preparation method and use thereof
CN104803938A PTP1B (protein tyrosine phosphatase 1B) inhibitors with phenylthiazole and cyclopentadiene structures and application of inhibitors
CN104803931A PTP (protein tyrosine phosphatase)1B inhibitors containing tetrazole structure as well as preparation methods and application of PTP1B inhibitors
CN104803940A PTP (protein tyrosine phosphatase)1B compounds containing thiazole and cyclopentadiene structures and application of PTP1B compounds
CN104803946A PTP1B (protein tyrosine phosphatase 1B) inhibitors with thiazolecarbonitrile and cyclopentadiene structures and application of inhibitors
CN104803933A PTP1B inhibitors containing tetrazole structures as well as preparation methods and applications of inhibitors
CN104803939A PTP1B (protein tyrosine phosphatase 1B) inhibitors with nitrothiazole and cyclopentadiene structures and application of inhibitors
CN104803944A Compounds containing cyclopentadiene and aniline structures and applications of compounds
CN104803977A PTP1B derivatives containing tetrazole structures as well as preparation methods and applications of derivatives
CN104803942A PTP (protein tyrosine phosphatase)1B inhibitors containing cyclopentadiene and alkoxyaniline structures and application of PTP1B inhibitors
CN104803945A PTP (protein tyrosine phosphatase)1B inhibitors containing phenylthiazole and cyclopentadiene structures and application of PTP1B inhibitors
CN104803937A Derivatives containing cyclopentadiene and aniline structures and applications of derivatives
CN104803943A PTP (protein tyrosine phosphatase)1B inhibitors containing cyclopentadiene and thioaniline structures and application of PTP1B inhibitors